Medication Guide - 1/14/2022

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Campath Alemtuzumab VIAL; INTRAVENOUS 103948 GENZYME 01/13/2022 Droxia Hydroxyurea CAPSULE;ORAL 016295 BRISTOL MYERS SQUIBB 01/13/2022 Hydrea Hydroxyurea CAPSULE;ORAL 016295 BRISTOL MYERS SQUIBB 01/13/2022 Lemtrada Alemtuzumab INJECTABLE;INJECTION 103948 GENZYME 01/13/2022 Topamax Topiramate TABLET;ORAL 020505 JANSSEN PHARMS 01/13/2022 Topamax Topiramate CAPSULE;ORAL 020844 JANSSEN PHARMS 01/13/2022 Topamax Sprinkle Topiramate CAPSULE;ORAL 020844 JANSSEN PHARMS 01/13/2022 Xospata Gilteritinib Fumarate TABLET;ORAL 211349 ASTELLAS 01/12/2022 Boniva Ibandronate Sodium INJECTABLE;INTRAVENOUS 021858 ROCHE 01/11/2022 Xiaflex Collagenase Clostridium Histolyticum SOLUTION; INJECTION 125338 AUXILIUM PHARMS 01/11/2022 Descovy Emtricitabine; Tenofovir Alafenamide Fumarate TABLET;ORAL 208215 GILEAD SCIENCES INC 01/07/2022 Quviviq Daridorexant TABLET; ORAL 214985 IDORSIA PHARMACEUTICALS LTD. 01/07/2022 Ultomiris Ravulizumab-Cwvz INJECTABLE;INJECTION 761108 ALEXION PHARM 01/07/2022 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA